drugset / Trial / NCT00902122
rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors
RandomizedParallel-groupOpen-labelTreatment
Summary
This is multicenter, open-label, randomized, active-controled, phase IV study of local direct intra-tumor injection of rAd-p53 monotherapy, with concurrent radioactive iodine , or combination with surgery for treatment of advanced malignant thyroid tumors.
Timeline
- Start
- 2009-05
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rAd-p53 | Unknown | 1e+12 vg | Other |